Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ASND CVE:GGI CVE:GRG CVE:IZN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASNDAscendis Pharma A/S$170.09+0.1%$169.61$111.09▼$183.00$10.39B0.38505,408 shs78,388 shsGGIGaribaldi ResourcesC$0.09+6.3%C$0.07C$0.05▼C$0.10C$11.69M0.547,893 shs63,000 shsGRGGolden Arrow ResourcesC$0.07+16.7%C$0.05C$0.04▼C$0.07C$11.23M1.1357,907 shs18,000 shsIZNInZinc MiningC$0.02-20.0%C$0.02C$0.02▼C$0.03C$2.47M3.7680,855 shs2,000 shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASNDAscendis Pharma A/S0.00%-2.89%-3.96%+5.43%+25.66%GGIGaribaldi Resources0.00%+13.33%+21.43%+21.43%-5.56%GRGGolden Arrow Resources0.00%+40.00%+55.56%+75.00%+55.56%IZNInZinc Mining0.00%-20.00%-33.33%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASNDAscendis Pharma A/S3.5726 of 5 stars4.53.00.00.02.71.70.6GGIGaribaldi ResourcesN/AN/AN/AN/AN/AN/AN/AN/AGRGGolden Arrow Resources1.4082 of 5 stars3.50.00.00.00.61.70.0IZNInZinc MiningN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASNDAscendis Pharma A/S 3.00Buy$223.0731.15% UpsideGGIGaribaldi Resources 0.00N/AN/AN/AGRGGolden Arrow Resources 3.00BuyC$0.21200.00% UpsideIZNInZinc Mining 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest IZN, ASND, GGI, and GRG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/11/2025ASNDAscendis Pharma A/SCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$213.00 ➝ $243.007/3/2025ASNDAscendis Pharma A/SMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$250.006/13/2025ASNDAscendis Pharma A/SOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$215.00 ➝ $224.006/9/2025ASNDAscendis Pharma A/SBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$201.00 ➝ $216.006/3/2025ASNDAscendis Pharma A/SBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$196.00 ➝ $201.005/12/2025ASNDAscendis Pharma A/SCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$200.00 ➝ $200.005/5/2025ASNDAscendis Pharma A/SMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$180.00 ➝ $250.005/2/2025ASNDAscendis Pharma A/SRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$205.00 ➝ $210.005/2/2025ASNDAscendis Pharma A/SJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$200.00 ➝ $245.005/2/2025ASNDAscendis Pharma A/SWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$181.00 ➝ $212.00(Data available from 7/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASNDAscendis Pharma A/S$393.54M26.43N/AN/A($1.88) per share-90.47GGIGaribaldi ResourcesN/AN/AC$0.00 per share17.31C$0.29 per shareN/AGRGGolden Arrow ResourcesN/AN/AC$0.04 per share1.94C$0.01 per shareN/AIZNInZinc MiningN/AN/AC$0.02 per share1.20C$0.02 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASNDAscendis Pharma A/S-$409.12M-$6.28N/A708.69N/A-93.22%N/A-33.29%9/2/2025 (Estimated)GGIGaribaldi Resources-C$956.85K-C$0.01N/A∞N/AN/A-2.41%-1.35%N/AGRGGolden Arrow Resources-C$6.83M-C$0.04N/A∞N/AN/A-152.41%-63.37%N/AIZNInZinc Mining-C$1.28MN/A2.00∞N/AN/A-16.50%-9.89%N/ALatest IZN, ASND, GGI, and GRG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/1/2025Q1 2025ASNDAscendis Pharma A/S-$1.56-$1.66-$0.10-$1.66$98.56 million$123.97 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASNDAscendis Pharma A/SN/AN/AN/AN/AN/AGGIGaribaldi ResourcesN/A4.63%N/AN/AN/AGRGGolden Arrow ResourcesN/AN/AN/AN/AN/AIZNInZinc MiningN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASNDAscendis Pharma A/SN/A1.040.71GGIGaribaldi ResourcesN/A0.021.51GRGGolden Arrow ResourcesN/A1.1715.33IZNInZinc MiningN/A26.5924.92Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASNDAscendis Pharma A/SN/AGGIGaribaldi ResourcesN/AGRGGolden Arrow ResourcesN/AIZNInZinc Mining3.24%Insider OwnershipCompanyInsider OwnershipASNDAscendis Pharma A/S40.00%GGIGaribaldi Resources24.60%GRGGolden Arrow Resources7.82%IZNInZinc Mining20.14%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASNDAscendis Pharma A/S1,01761.15 million36.69 millionOptionableGGIGaribaldi ResourcesN/A137.50 millionN/ANot OptionableGRGGolden Arrow ResourcesN/A160.42 millionN/ANot OptionableIZNInZinc MiningN/A123.40 millionN/ANot OptionableIZN, ASND, GGI, and GRG HeadlinesRecent News About These CompaniesInZinc Mobilizes to Drill Test for Extensions to Sedex Zn-Pb-Ag Discovery at Indy Project, Central BCMay 29, 2025 | finance.yahoo.comInZinc Mining Mobilizes to Drill Test for Extensions to Sedex Zn-Pb-Ag Discovery at Indy Project, Central BCMay 29, 2025 | juniorminingnetwork.comInZinc Mining Initiates Drilling to Expand Indy Sedex ProjectMay 29, 2025 | tipranks.comIZN:CA InZinc Mining Ltd.April 17, 2025 | seekingalpha.comInZinc Prepares for 2025 Drill Program at Indy Project in Central BCApril 15, 2025 | goldseiten.deInZinc Mining Ltd. Prepares for 2025 Drill Program at Indy Project in Central BCApril 15, 2025 | goldseiten.deInZinc Mining Discovers New Anomaly Supporting Extension of Near Surface Mineralization at Indy Sedex Project, Central BCFebruary 24, 2025 | juniorminingnetwork.comInZinc Discovers New Anomaly Supporting Extension of Near Surface Mineralization at Indy Sedex Project, Central BCFebruary 24, 2025 | finance.yahoo.comInZinc Mining Unveils New Anomaly at Indy Project, Signaling Expansion PotentialFebruary 24, 2025 | tipranks.comOil prices fall 2% on economic worries, technical declineAugust 29, 2024 | ca.finance.yahoo.comSony hikes the PlayStation 5 price in Japan by 19 percentAugust 29, 2024 | ca.finance.yahoo.comInZinc Mining Continues to Advance New Large-Scale Sedex Zn-Pb-Ag Targets at Indy Project, Central BCAugust 29, 2024 | juniorminingnetwork.comInZinc Continues to Advance New Large-Scale Sedex Zn-Pb-Ag Targets at Indy Project, Central BCAugust 27, 2024 | msn.comInZinc Receives 5-Year Drill Permit Renewal and Provides Exploration Update at Indy Project in Central BCJuly 26, 2024 | finance.yahoo.comInZinc Mining Receives 5-Year Drill Permit Renewal and Provides Exploration Update at Indy Project in Central BCJuly 26, 2024 | juniorminingnetwork.comClosing Bell: Inzinc Mining Ltd flat on Monday (IZN)May 27, 2024 | theglobeandmail.comCanadian Investment Regulatory Organization Trade Resumption - IZNMay 16, 2024 | ca.finance.yahoo.comInZinc Announces Key Correlations to One of the World's Most Prolific Zinc-Lead-Silver Belts, the Selwyn Basin, at the Indy Project in Central BCMay 16, 2024 | stockhouse.comInZinc Reports Exceptional Barite Intersections at Indy - Planning for Upcoming ExplorationMay 2, 2024 | stockhouse.comInZinc Mining Reports High Grade Barite and Extends Barite Trend to 700 m Strike LengthApril 17, 2024 | juniorminingnetwork.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeIZN, ASND, GGI, and GRG Company DescriptionsAscendis Pharma A/S NASDAQ:ASND$170.08 +0.19 (+0.11%) As of 11:27 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.Garibaldi Resources CVE:GGIC$0.08 +0.01 (+6.25%) As of 10:58 AM EasternGaribaldi Resources Corp., an exploration stage company, engages in the acquisition, exploration, and evaluation of mineral properties in Canada and Mexico. The company explores for nickel, copper, cobalt, platinum, palladium, gold, and silver deposits. Its flagship property is 100% owned E&L Nickel Mountain Project located to Northwest British Columbia. The company was incorporated in 1993 and is headquartered in Vancouver, Canada.Golden Arrow Resources CVE:GRGC$0.07 +0.01 (+16.67%) As of 09:30 AM EasternGolden Arrow Resources Corporation, a natural resource company, engages in the acquisition, exploration, and development resource properties in South America. The company explores for iron, copper, gold, cobalt, and silver deposits. Its flagship project is the 100% owned San Pietro Fe-Cu-Au-Co Project covering an area of 18,448 Ha located in Chile. Golden Arrow Resources Corporation was incorporated in 2015 and is based in Vancouver, Canada.Golden Arrow Resources Corporation operates as a subsidiary of Grosso Group Management Ltd.InZinc Mining CVE:IZNC$0.02 -0.01 (-20.00%) As of 07/15/2025InZinc Mining Ltd. acquires, explores for, and develops mineral properties in the United States and Canada. It primarily explores for zinc, copper, and indium deposits. The company holds a 100% interest in the Indy project comprising an area of 19,000 hectares located in Central British Colombia; and the West Desert Property located in Utah, the United States. The company was formerly known as Lithic Resources Ltd. and changed its name to InZinc Mining Ltd. in February 2014. InZinc Mining Ltd. was incorporated in 1997 and is headquartered in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/14 - 07/18 Q2 Could Be the Catalyst PayPal Investors Have Been Waiting For Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
